Haemonetics HAE Cash Flow Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| —— | $175.44M+34.9% | $168.19M+35.8% | $163.34M+42.2% | $167.68M+42.6% | ||
| $111.72M-3.3% | $112.61M-2.1% | $114.25M+4.3% | $115.21M+11.5% | $115.59M+18.9% | ||
| $33.83M+14.1% | $31.64M+5.0% | $32.05M+10.1% | $31.32M+8.1% | $29.64M+4.6% | ||
| $95.13M— | —— | —— | —— | —— | ||
| $714K-95.5% | $1.66M-88.9% | $1.6M-89.3% | $1.84M-87.6% | $15.7M+1,450% | ||
| $14.88M+314% | -$17.69M— | -$4.86M— | -$2.54M— | -$6.96M— | ||
| -$47.36M-173% | -$38.54M-146% | -$7.36M-110% | $25.18M-62.4% | $64.7M+7.7% | ||
| —— | —— | —— | —— | —— | ||
| $10.73M+7.5% | $6.62M-52.7% | $8.13M-42.1% | $9.87M-16.6% | $9.98M-14.2% | ||
| $293.22M+61.4% | $338.84M+162% | $289.04M+238% | $226.54M+66.8% | $181.73M-0.3% | ||
| $32.78M-16.5% | $30.76M+1.5% | $32.96M-9.5% | $37.38M+3.5% | $39.28M+3.0% | ||
| $60.18M— | —— | —— | —— | —— | ||
| $36.07M+110% | $39.67M+109% | $32.74M+73.1% | $34.69M+244% | $17.14M+10.2% | ||
| $1.38M-94.1% | $3.3M-84.5% | $3.12M-85.5% | $3.65M-82.9% | $23.25M+1,185% | ||
| -$179.55M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $0— | —— | —— | —— | —— | ||
| $0-100% | $6.25M-5.6% | $6.25M-27.0% | $4.69M-61.1% | $4.69M-61.7% | ||
| —— | —— | —— | —— | —— | ||
| $5M-51.2% | $4.96M-51.6% | $5.24M-46.7% | $5.27M-62.7% | $10.24M+74.1% | ||
| -$102K+59.0% | -$116K+64.8% | -$251K-38.7% | -$223K-27.4% | -$249K+74.5% | ||
| $0— | —— | —— | —— | —— | ||
| -$180.49M— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$64.85M— | —— | —— | —— | —— | ||
| $5.81M-61.1% | $8.45M-46.1% | $10.47M-15.1% | $12.15M+41.5% | $14.96M+347% | ||
| $95.13M— | —— | —— | —— | —— | ||
| -$1.88M+91.8% | -$7.16M+58.5% | -$12.45M-8.2% | -$17.74M-208% | -$23.02M— | ||
| $0— | —— | —— | —— | —— | ||
| —— | —— | —— | -$349K+45.9% | -$226K-123% | ||
| $36.07M+110% | $39.67M+109% | $32.74M+73.1% | $34.69M+244% | $17.14M+10.2% | ||
| $1.38M-94.1% | $3.3M-84.5% | $3.12M-85.5% | $3.65M-82.9% | $23.25M+1,185% | ||
| -$51.89M-146% | -$51.06M-226% | -$43.51M-150% | -$28.36M+6.7% | -$21.11M+25.1% | ||
| —— | —— | —— | —— | —— | ||
| $0— | —— | —— | —— | —— | ||
| $7.89M-5.3% | $7.96M-1.6% | $8.37M+7.5% | $8.37M+7.5% | $8.33M+15.5% | ||
| $0-100% | $22.05M-66.7% | $44.1M0.0% | $66.15M+200% | $88.2M— | ||
| $0— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$102K+59.0% | -$116K+64.8% | -$251K-38.7% | -$223K-27.4% | -$249K+74.5% | ||
| —— | —— | —— | —— | —— | ||
| $300M+61.7% | $271.38M+95.1% | $242.75M+162% | $214.13M+362% | $185.5M— | ||
| $0— | —— | —— | —— | —— | ||
| $0-100% | $62.5M-66.7% | $125M0.0% | $187.5M+200% | $250M— | ||
| $47.26M— | $35.44M— | $23.63M— | $11.81M— | $0— | ||
| $35.81M— | $26.86M— | $17.91M— | $8.95M— | $0— | ||
| $260.44M+82.8% | $308.08M+211% | $256.08M— | $189.17M— | $142.45M— | ||
| $260.44M+82.8% | $308.08M+211% | $256.08M— | $189.17M— | $142.45M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Haemonetics's cash flow data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.